Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd)(Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd))

概要

基本信息

药物类型

重组多肽

别名-

靶点

GLP-1R

作用机制

GLP-1R激动剂(胰高血糖素样肽-1激动剂)

治疗领域

内分泌与代谢疾病

在研适应症-

非在研适应症

2型糖尿病

原研机构

东莞宝丽健生物工程研究开发有限公司

在研机构-

非在研机构

东莞宝丽健生物工程研究开发有限公司

最高研发阶段暂停临床前

首次获批日期-

最高研发阶段(中国)暂停

特殊审评-

关联

1

项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的临床试验

ChiCTR2300074467

/ SuspendedIIT

The Clinical Research of Exendin-4 PET/CT for Imaging of Insulinoma

开始日期2023-08-15

申办/合作机构

复旦大学附属肿瘤医院

100 项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的临床结果

登录后查看更多信息

100 项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的转化医学

登录后查看更多信息

100 项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的专利（医药）

登录后查看更多信息

2

项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的文献（医药）

2020-12-11·Science advances1区 · 综合性期刊

Visualizing subcellular rearrangements in intact β cells using soft x-ray tomography

1区 · 综合性期刊

ArticleOA

作者: Francis, John Paul ; Chen, Jian-Hua ; White, Kate L. ; Li, Angdi ; Ekman, Axel ; Alber, Frank ; Sali, Andrej ; Sun, Liping ; Loconte, Valentina ; Tseng, Kaylee ; Zhang, Xianjun ; Singla, Jitin ; McDermott, Gerry ; Lin, Wen ; Stevens, Raymond C. ; Larabell, Carolyn

Subcellular maps of β cells reveal the coordinated reorganization of organelles during insulin secretion.

Dalton transactions (Cambridge, England : 2003)2区 · 化学

Noble-metal-free MoS₂ nanosheet modified-InVO₄ heterostructures for enhanced visible-light-driven photocatalytic H₂ production

2区 · 化学

Article

作者: Yang, Shuhui ; Chen, Daqin ; Yuan, Yong-Jun ; Fang, Gaoliang ; Cao, Dapeng ; Kong, Zhe ; Yang, Yan

Noble-metal-free, visible-light-responding and “green” MoS₂ nanosheet modified-InVO₄ heterostructures were synthesized as efficient photocatalysts for photocatalytic H₂ production.

100 项与 Exendin-4(Dongguan Baolijian Bioengineering Research And Development Co Ltd) 相关的药物交易

登录后查看更多信息